$REGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in REGENERON PHARMACEUTICALS, INC.. Get notifications about new insider transactions in REGENERON PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 ... 48 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Sell | S | 603.20 | 693 | 418,018 | 1,433 | 2.1 K to 1.4 K (-32.60 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Sell | S | 602.39 | 12,899 | 7,770,229 | 2,126 | 15 K to 2.1 K (-85.85 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Sell | S | 601.53 | 8,011 | 4,818,857 | 15,025 | 23 K to 15 K (-34.78 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Sell | S | 600.44 | 12,490 | 7,499,496 | 23,036 | 35.5 K to 23 K (-35.16 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Sell | S | 599.67 | 5,730 | 3,436,109 | 35,526 | 41.3 K to 35.5 K (-13.89 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Sell | S | 598.91 | 177 | 106,007 | 41,256 | 41.4 K to 41.3 K (-0.43 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Buy | M | 25.45 | 25,000 | 636,250 | 41,433 | 16.4 K to 41.4 K (+152.13 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Buy | M | 33.42 | 15,000 | 501,300 | 16,433 | 1.4 K to 16.4 K (+1,046.76 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 273.67 | 12,750 | 3,489,293 | 0 | |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 612.00 | 1,000 | 612,000 | 3,700 | 4.7 K to 3.7 K (-21.28 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 614.15 | 300 | 184,245 | 64,415 | 64.7 K to 64.4 K (-0.46 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 613.39 | 800 | 490,712 | 64,715 | 65.5 K to 64.7 K (-1.22 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 612.43 | 1,900 | 1,163,617 | 65,515 | 67.4 K to 65.5 K (-2.82 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 611.60 | 3,840 | 2,348,544 | 67,415 | 71.3 K to 67.4 K (-5.39 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 610.42 | 3,793 | 2,315,323 | 71,255 | 75 K to 71.3 K (-5.05 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 609.67 | 760 | 463,349 | 75,048 | 75.8 K to 75 K (-1.00 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 608.06 | 300 | 182,418 | 75,808 | 76.1 K to 75.8 K (-0.39 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 607.46 | 2,384 | 1,448,185 | 76,108 | 78.5 K to 76.1 K (-3.04 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 606.43 | 5,168 | 3,134,030 | 78,492 | 83.7 K to 78.5 K (-6.18 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 605.53 | 4,700 | 2,845,991 | 83,660 | 88.4 K to 83.7 K (-5.32 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 604.43 | 3,705 | 2,239,413 | 88,360 | 92.1 K to 88.4 K (-4.02 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 603.53 | 3,000 | 1,810,590 | 92,065 | 95.1 K to 92.1 K (-3.16 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 602.68 | 400 | 241,072 | 95,065 | 95.5 K to 95.1 K (-0.42 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 601.75 | 300 | 180,525 | 95,465 | 95.8 K to 95.5 K (-0.31 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 600.36 | 1,400 | 840,504 | 95,765 | 97.2 K to 95.8 K (-1.44 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 273.67 | 12,750 | 3,489,293 | 97,165 | 84.4 K to 97.2 K (+15.10 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 614.24 | 1,288 | 791,141 | 20,001 | 21.3 K to 20 K (-6.05 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 613.62 | 1,560 | 957,247 | 21,289 | 22.8 K to 21.3 K (-6.83 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 612.49 | 4,044 | 2,476,910 | 22,849 | 26.9 K to 22.8 K (-15.04 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 611.40 | 1,980 | 1,210,572 | 26,893 | 28.9 K to 26.9 K (-6.86 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 610.41 | 7,981 | 4,871,682 | 28,873 | 36.9 K to 28.9 K (-21.66 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 609.71 | 10,256 | 6,253,186 | 36,854 | 47.1 K to 36.9 K (-21.77 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 177.82 | 10,037 | 1,784,779 | 0 | |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 177.82 | 4,963 | 882,521 | 10,037 | |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 57.11 | 5,000 | 285,550 | 0 | |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 57.11 | 10,000 | 571,100 | 5,000 | |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 593.23 | 136 | 80,679 | 84,415 | 84.6 K to 84.4 K (-0.16 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 592.28 | 5,626 | 3,332,167 | 84,551 | 90.2 K to 84.6 K (-6.24 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 597.93 | 135 | 80,721 | 90,177 | 90.3 K to 90.2 K (-0.15 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 596.56 | 1,303 | 777,318 | 90,312 | 91.6 K to 90.3 K (-1.42 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 595.43 | 1,400 | 833,602 | 91,615 | 93 K to 91.6 K (-1.51 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 594.30 | 1,400 | 832,020 | 93,015 | 94.4 K to 93 K (-1.48 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 593.11 | 200 | 118,622 | 94,415 | 94.6 K to 94.4 K (-0.21 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 592.27 | 5,741 | 3,400,222 | 94,615 | 100.4 K to 94.6 K (-5.72 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 597.46 | 188 | 112,322 | 100,356 | 100.5 K to 100.4 K (-0.19 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 596.63 | 1,100 | 656,293 | 100,544 | 101.6 K to 100.5 K (-1.08 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 595.43 | 1,607 | 956,856 | 101,644 | 103.3 K to 101.6 K (-1.56 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 594.30 | 1,201 | 713,754 | 103,251 | 104.5 K to 103.3 K (-1.15 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 177.82 | 10,037 | 1,784,779 | 104,452 | 94.4 K to 104.5 K (+10.63 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 605.05 | 9,800 | 5,929,490 | 94,415 | 104.2 K to 94.4 K (-9.40 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 608.15 | 200 | 121,630 | 104,215 | 104.4 K to 104.2 K (-0.19 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 605.04 | 9,663 | 5,846,502 | 104,415 | 114.1 K to 104.4 K (-8.47 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 57.11 | 5,000 | 285,550 | 114,078 | 109.1 K to 114.1 K (+4.58 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 608.06 | 300 | 182,418 | 109,078 | 109.4 K to 109.1 K (-0.27 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 177.82 | 4,963 | 882,521 | 109,378 | 104.4 K to 109.4 K (+4.75 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 619.33 | 560 | 346,825 | 104,415 | 105 K to 104.4 K (-0.53 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 618.57 | 1,152 | 712,593 | 104,975 | 106.1 K to 105 K (-1.09 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 617.68 | 3,371 | 2,082,199 | 106,127 | 109.5 K to 106.1 K (-3.08 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 616.26 | 1,627 | 1,002,655 | 109,498 | 111.1 K to 109.5 K (-1.46 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 615.48 | 3,290 | 2,024,929 | 111,125 | 114.4 K to 111.1 K (-2.88 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 57.11 | 10,000 | 571,100 | 114,415 | 104.4 K to 114.4 K (+9.58 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 619.29 | 703 | 435,361 | 104,415 | 105.1 K to 104.4 K (-0.67 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 618.49 | 1,318 | 815,170 | 105,118 | 106.4 K to 105.1 K (-1.24 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 617.64 | 3,454 | 2,133,329 | 106,436 | 109.9 K to 106.4 K (-3.14 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 616.25 | 1,742 | 1,073,508 | 109,890 | 111.6 K to 109.9 K (-1.56 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 615.51 | 3,783 | 2,328,474 | 111,632 | 115.4 K to 111.6 K (-3.28 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 617.18 | 1,000 | 617,180 | 5,643 | 6.6 K to 5.6 K (-15.05 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | M | 179.13 | 75,000 | 13,434,750 | 0 | |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Payment of Exercise | F | 614.09 | 47,891 | 29,409,384 | 47,110 | 95 K to 47.1 K (-50.41 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Buy | M | 179.13 | 75,000 | 13,434,750 | 95,001 | 20 K to 95 K (+374.98 %) |
| Aug 13 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Sell | S | 607.43 | 998 | 606,215 | 50,192 | 51.2 K to 50.2 K (-1.95 %) |
| Aug 13 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Sell | S | 606.51 | 2,684 | 1,627,873 | 51,190 | 53.9 K to 51.2 K (-4.98 %) |
| Aug 13 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Sell | S | 605.41 | 3,331 | 2,016,621 | 53,874 | 57.2 K to 53.9 K (-5.82 %) |
| Aug 13 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Sell | S | 604.35 | 3,171 | 1,916,394 | 57,205 | 60.4 K to 57.2 K (-5.25 %) |
| Aug 13 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Sell | S | 603.54 | 8,622 | 5,203,722 | 60,376 | 69 K to 60.4 K (-12.50 %) |
| Aug 13 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Sell | S | 602.66 | 3,769 | 2,271,426 | 68,998 | 72.8 K to 69 K (-5.18 %) |
| Aug 13 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Sell | S | 601.42 | 3,281 | 1,973,259 | 72,767 | 76 K to 72.8 K (-4.31 %) |
| Aug 13 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Sell | S | 600.30 | 4,851 | 2,912,055 | 76,048 | 80.9 K to 76 K (-6.00 %) |
| Aug 13 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Sell | S | 599.37 | 718 | 430,348 | 80,899 | 81.6 K to 80.9 K (-0.88 %) |
| Aug 13 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Sell | S | 598.52 | 843 | 504,552 | 81,617 | 82.5 K to 81.6 K (-1.02 %) |
| Aug 13 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Sell | S | 597.74 | 950 | 567,853 | 82,460 | 83.4 K to 82.5 K (-1.14 %) |
| Aug 13 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Sell | S | 595.69 | 162 | 96,502 | 83,410 | 83.6 K to 83.4 K (-0.19 %) |
| Aug 13 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Sell | S | 594.20 | 80 | 47,536 | 83,572 | 83.7 K to 83.6 K (-0.10 %) |
| Aug 13 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 341 | 0 | 143,559 | 143.9 K to 143.6 K (-0.24 %) |
| Aug 13 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 73,100 | 0 | 234,649 | 307.7 K to 234.6 K (-23.75 %) |
| Aug 05 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 647.03 | 2 | 1,294 | 28,543 | 28.5 K to 28.5 K (-0.01 %) |
| Aug 05 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 646.26 | 17 | 10,986 | 28,545 | 28.6 K to 28.5 K (-0.06 %) |
| Aug 05 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 645.64 | 12 | 7,748 | 28,562 | 28.6 K to 28.6 K (-0.04 %) |
| Aug 05 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 644.34 | 6 | 3,866 | 28,574 | 28.6 K to 28.6 K (-0.02 %) |
| Aug 05 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 643.50 | 15 | 9,653 | 28,580 | 28.6 K to 28.6 K (-0.05 %) |
| Aug 05 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 642.51 | 7 | 4,498 | 28,595 | 28.6 K to 28.6 K (-0.02 %) |
| Aug 05 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 641.52 | 7 | 4,491 | 28,602 | 28.6 K to 28.6 K (-0.02 %) |
| Aug 05 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 640.35 | 1 | 640 | 28,609 | 28.6 K to 28.6 K (0.00 %) |
| Aug 05 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 639.99 | 1 | 640 | 28,610 | 28.6 K to 28.6 K (0.00 %) |
| Aug 05 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 638.51 | 12 | 7,662 | 28,611 | 28.6 K to 28.6 K (-0.04 %) |
| Aug 05 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 637.47 | 6 | 3,825 | 28,623 | 28.6 K to 28.6 K (-0.02 %) |
| Aug 05 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 636.46 | 4 | 2,546 | 28,629 | 28.6 K to 28.6 K (-0.01 %) |
| Aug 05 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 635.52 | 2 | 1,271 | 28,633 | 28.6 K to 28.6 K (-0.01 %) |
| Aug 05 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 634.60 | 5 | 3,173 | 28,635 | 28.6 K to 28.6 K (-0.02 %) |
| Aug 05 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 633.78 | 3 | 1,901 | 28,640 | 28.6 K to 28.6 K (-0.01 %) |
| Aug 05 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 654.46 | 696 | 455,504 | 23,973 | 24.7 K to 24 K (-2.82 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 179.13 | 10,000 | 1,791,300 | 13,500 | |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 52.03 | 2,224 | 115,715 | 0 | |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 658.00 | 11 | 7,238 | 17,501 | 17.5 K to 17.5 K (-0.06 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 647.79 | 82 | 53,119 | 17,512 | 17.6 K to 17.5 K (-0.47 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 646.82 | 155 | 100,257 | 17,594 | 17.7 K to 17.6 K (-0.87 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 645.33 | 72 | 46,464 | 17,749 | 17.8 K to 17.7 K (-0.40 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 644.57 | 303 | 195,305 | 17,821 | 18.1 K to 17.8 K (-1.67 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 643.49 | 691 | 444,652 | 18,124 | 18.8 K to 18.1 K (-3.67 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 642.39 | 676 | 434,256 | 18,815 | 19.5 K to 18.8 K (-3.47 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 641.58 | 855 | 548,551 | 19,491 | 20.3 K to 19.5 K (-4.20 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 640.61 | 113 | 72,389 | 20,346 | 20.5 K to 20.3 K (-0.55 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 639.64 | 75 | 47,973 | 20,459 | 20.5 K to 20.5 K (-0.37 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 638.51 | 306 | 195,384 | 20,534 | 20.8 K to 20.5 K (-1.47 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 637.88 | 154 | 98,234 | 20,840 | 21 K to 20.8 K (-0.73 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 636.56 | 216 | 137,497 | 20,994 | 21.2 K to 21 K (-1.02 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 52.03 | 2,224 | 115,715 | 21,210 | 19 K to 21.2 K (+11.71 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Payment of Exercise | F | 655.57 | 6,291 | 4,124,191 | 18,986 | 25.3 K to 19 K (-24.89 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 179.13 | 10,000 | 1,791,300 | 25,277 | 15.3 K to 25.3 K (+65.46 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 555.67 | 5,000 | 2,778,350 | 5,000 | |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 399.66 | 3,500 | 1,398,810 | 25,000 | |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 658.00 | 3 | 1,974 | 24,669 | 24.7 K to 24.7 K (-0.01 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 647.50 | 388 | 251,230 | 24,672 | 25.1 K to 24.7 K (-1.55 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 655.57 | 4,611 | 3,022,833 | 25,060 | 29.7 K to 25.1 K (-15.54 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 555.67 | 5,000 | 2,778,350 | 29,671 | 24.7 K to 29.7 K (+20.27 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 655.57 | 2,802 | 1,836,907 | 24,671 | 27.5 K to 24.7 K (-10.20 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 399.66 | 3,500 | 1,398,810 | 27,473 | 24 K to 27.5 K (+14.60 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Option Exercise | M | 30.63 | 13,000 | 398,190 | 13,736 | |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 639.55 | 79 | 50,524 | 41,951 | 42 K to 42 K (-0.19 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 638.96 | 239 | 152,711 | 42,030 | 42.3 K to 42 K (-0.57 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 637.48 | 182 | 116,021 | 42,269 | 42.5 K to 42.3 K (-0.43 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 635.46 | 175 | 111,206 | 42,451 | 42.6 K to 42.5 K (-0.41 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 634.18 | 89 | 56,442 | 42,626 | 42.7 K to 42.6 K (-0.21 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 633.02 | 95 | 60,137 | 42,715 | 42.8 K to 42.7 K (-0.22 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 632.12 | 679 | 429,209 | 42,810 | 43.5 K to 42.8 K (-1.56 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 631.32 | 578 | 364,903 | 43,489 | 44.1 K to 43.5 K (-1.31 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 630.77 | 264 | 166,523 | 44,067 | 44.3 K to 44.1 K (-0.60 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 629.58 | 852 | 536,402 | 44,331 | 45.2 K to 44.3 K (-1.89 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 628.50 | 950 | 597,075 | 45,183 | 46.1 K to 45.2 K (-2.06 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 626.66 | 83 | 52,013 | 46,133 | 46.2 K to 46.1 K (-0.18 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 625.05 | 4 | 2,500 | 46,216 | 46.2 K to 46.2 K (-0.01 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 624.77 | 487 | 304,263 | 46,220 | 46.7 K to 46.2 K (-1.04 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 622.51 | 1 | 623 | 46,707 | 46.7 K to 46.7 K (0.00 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 621.06 | 113 | 70,180 | 46,708 | 46.8 K to 46.7 K (-0.24 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 620.94 | 81 | 50,296 | 46,821 | 46.9 K to 46.8 K (-0.17 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 619.28 | 162 | 100,323 | 46,902 | 47.1 K to 46.9 K (-0.34 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 618.39 | 255 | 157,689 | 47,064 | 47.3 K to 47.1 K (-0.54 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 617.64 | 304 | 187,763 | 47,319 | 47.6 K to 47.3 K (-0.64 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 616.34 | 256 | 157,783 | 47,623 | 47.9 K to 47.6 K (-0.53 %) |
| Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 615.59 | 203 | 124,965 | 47,879 | 48.1 K to 47.9 K (-0.42 %) |